As of Sep 19
| +0.07 / +2.10%|
The 3 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +135.29% increase from the last price of 3.40.
The current consensus among 3 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.